COLUMBIA, Mo.--(BUSINESS WIRE)--Endevica Bio, a company developing best-in-class peptide drug candidates with better safety and efficacy properties, presented new data from a recent preclinical study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results